| Financial Year |
March 31 2023 |
| Monetary Funds |
506,977,251.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
150,962,935.14 |
| Accounts Receivable |
1,216,256,380.28 |
| Advances to Suppliers |
1,250,260,095.45 |
| Other Receivables |
491,270,747.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,742,293,589.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,500,000.00 |
| Other Current Assets |
52,162,189.62 |
| Total Current Assets |
6,673,954,469.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
53,931,891.46 |
| Long-term Equity Investment |
1,037,967,334.70 |
| Investment Properties |
-- |
| Fixed Assetes |
3,334,999,308.42 |
| Under-construction Projects |
104,619,454.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
582,717,090.73 |
| R&D expenses |
188,899,519.38 |
| Goodwill |
64,656,693.34 |
| Long-Term Deferred and Prepaid Expenses |
20,436,364.65 |
| Deferred Income Tax Assets |
296,002,858.36 |
| Other Non-Current Assets |
88,890,823.74 |
| Sub-Total of Non-Current Assets |
8,430,235,102.39 |
| Total Assets |
15,104,189,572.20 |
| Short-Term Loans |
521,078,580.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
63,136,088.31 |
| Accounts Payable |
1,574,211,231.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,869,681.77 |
| Taxes Payable |
11,009,160.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,317,850,035.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,271,492,117.04 |
| Other Current Liabilities |
286,665,675.98 |
| Sub-Total of Current Liabilities |
6,614,495,475.28 |
| Long-term Loans |
682,213,382.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
315,982,997.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,111,483.81 |
| Deferred Income Tax Liabilities |
33,157,015.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,141,789,146.36 |
| Total Liabilities |
7,756,284,621.64 |
| Paid-In Capital(Or Share Stock) |
2,349,720,302.00 |
| Capital Surplus |
1,034,669,202.83 |
| Surplus Reserve |
477,568,783.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,998,596,890.87 |
| Minority Stockholder's Interest |
484,620,727.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,863,284,222.99 |
| Owner's Equity（Stockholder's Equity） |
7,347,904,950.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,104,189,572.20 |
